{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:33:43Z","timestamp":1793370823786,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clinme.2026.100652","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:19:33Z","timestamp":1791123573000},"page":"100652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modern multidisciplinary management of brain metastasis"],"prefix":"10.1016","volume":"26","author":[{"family":"Melyda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ozair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean E.H.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5551-4338","authenticated-orcid":false,"given":"Irene S.","family":"Guterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9034-4100","authenticated-orcid":false,"given":"Faisal","family":"Fa\u2019ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmeet S.","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-830X","authenticated-orcid":false,"given":"Paul M.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahua","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1994-2878","authenticated-orcid":false,"given":"Samuel","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4159-8697","authenticated-orcid":false,"given":"Vinton W.T.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinme.2026.100652_bib1","first-page":"10","article-title":"Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSG","volume":"5","author":"Kurian","year":"2018","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.clinme.2026.100652_bib2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.clinme.2026.100652_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.clinme.2026.100652_bib4","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/cncr.25707","article-title":"Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?","volume":"117","author":"Nieder","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clinme.2026.100652_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s43856-024-00445-7","article-title":"Estimating the risk of brain metastasis for patients newly diagnosed with cancer","volume":"4","author":"Miccio","year":"2024","journal-title":"Commun Med"},{"issue":"8","key":"10.1016\/j.clinme.2026.100652_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.clinme.2026.100652_bib7","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","article-title":"Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC","volume":"389","author":"Planchard","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.clinme.2026.100652_bib8","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1038\/s41591-024-03261-7","article-title":"Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b\/4 trial","volume":"30","author":"Harbeck","year":"2024","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.clinme.2026.100652_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/neuonc\/noaa030","article-title":"Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases","volume":"22","author":"Kaufmann","year":"2020","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.clinme.2026.100652_bib10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"issue":"11","key":"10.1016\/j.clinme.2026.100652_bib11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clinme.2026.100652_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00165531","article-title":"Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases","volume":"11","author":"Weissman","year":"1991","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.clinme.2026.100652_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1212\/WNL.44.4.675","article-title":"Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day","volume":"44","author":"Vecht","year":"1994","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.clinme.2026.100652_bib14","doi-asserted-by":"crossref","first-page":"E607","DOI":"10.1093\/neuros\/nyz186","article-title":"Letter: when less is more: dexamethasone dosing for brain tumors","volume":"85","author":"Lim-Fat","year":"2019","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.clinme.2026.100652_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.surneu.2006.11.065","article-title":"Bone health in patients with brain tumors","volume":"68","author":"Da Silva","year":"2007","journal-title":"Surg Neurol"},{"issue":"2","key":"10.1016\/j.clinme.2026.100652_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jama.2023.9844","article-title":"Prophylaxis against pneumocystis jirovecii pneumonia in adults","volume":"330","author":"Zhou","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clinme.2026.100652_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/neuonc\/noz034","article-title":"Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines","volume":"21","author":"Chang","year":"2019","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.clinme.2026.100652_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/neuonc\/noaa298","article-title":"Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors","volume":"23","author":"Le Rhun","year":"2021","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.clinme.2026.100652_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healthpol.2014.09.006","article-title":"Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes","volume":"119","author":"Prades","year":"2015","journal-title":"Health Policy"},{"key":"10.1016\/j.clinme.2026.100652_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1160802","article-title":"Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer","volume":"13","author":"Xu","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.clinme.2026.100652_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clinme.2026.100652_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clinme.2026.100652_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.03.020","volume":"114","author":"Sperduto","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clinme.2026.100652_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clinme.2026.100652_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-024-04739-7","article-title":"Defining the role of surgery for patients with multiple brain metastases","volume":"169","author":"Ersoy","year":"2024","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.clinme.2026.100652_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.prro.2011.12.004","article-title":"Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline","volume":"2","author":"Tsao","year":"2012","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clinme.2026.100652_bib27","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/neuros\/nyy542","article-title":"Congress of neurological surgeons systematic review and evidence-based guidelines on the role of surgery in the management of adults with metastatic brain tumors","volume":"84","author":"Nahed","year":"2019","journal-title":"Neurosurgery"},{"issue":"12","key":"10.1016\/j.clinme.2026.100652_bib28","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/neuonc\/noaf182","article-title":"Hypofractionated stereotactic radiotherapy versus whole-brain radiotherapy following brain metastasis resection: results of the ESTRON randomized phase 2 trial","volume":"27","author":"El Shafie","year":"2025","journal-title":"Neuro Oncol"},{"issue":"8","key":"10.1016\/j.clinme.2026.100652_bib29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncology"},{"issue":"8","key":"10.1016\/j.clinme.2026.100652_bib30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinme.2026.100652_bib31","series-title":"Excellence","article-title":"NG99: brain tumours (primary) and brain metastases in adults","author":"NICE","year":"2018"},{"issue":"4","key":"10.1016\/j.clinme.2026.100652_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","article-title":"Radiation therapy for brain metastases: an ASTRO clinical practice guideline","volume":"12","author":"Gondi","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"11","key":"10.1016\/j.clinme.2026.100652_bib33","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO\u2013ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours \u2729","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.clinme.2026.100652_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1\u20133 Brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.clinme.2026.100652_bib35","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/jama.2026.0076","article-title":"Treatment for brain metastases with stereotactic radiation vs hippocampal-avoidance whole brain radiation: a randomized clinical trial","volume":"335","author":"Aizer","year":"2026","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.clinme.2026.100652_bib36","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2019.03.052","article-title":"Initial SRS for patients with 5\u201315 brain metastases: results of a multi-institutional experience","volume":"104","author":"Hughes","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clinme.2026.100652_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.adro.2019.08.013","article-title":"Single-isocenter multitarget stereotactic radiosurgery is safe and effective in the treatment of multiple brain metastases","volume":"5","author":"Palmer","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"8","key":"10.1016\/j.clinme.2026.100652_bib38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.clinme.2026.100652_bib39","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clinme.2026.100652_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-025-01013-1","article-title":"Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care","volume":"22","author":"Mansouri","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10.1016\/j.clinme.2026.100652_bib41","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/neuonc\/noz046","article-title":"The impact of sequencing PD-1\/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis","volume":"21","author":"Kotecha","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.clinme.2026.100652_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2018.08.025","article-title":"Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: an international meta-analysis of individual patient data","volume":"130","author":"Lehrer","year":"2019","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clinme.2026.100652_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-018-03020-y","article-title":"Concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for metastatic brain disease: a systematic review and meta-analysis","volume":"141","author":"Lu","year":"2019","journal-title":"J Neurooncol"},{"issue":"Suppl 3","key":"10.1016\/j.clinme.2026.100652_bib44","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose-volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"10.1016\/j.clinme.2026.100652_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17213542","article-title":"Radiation necrosis in neuro-oncology: diagnostic complexity and precision radiotherapy strategies","volume":"17","author":"Mittelman","year":"2025","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.clinme.2026.100652_bib46","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1007\/s00330-020-07514-0","article-title":"Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis","volume":"31","author":"Kim","year":"2021","journal-title":"Eur Radiol"},{"issue":"Suppl 17","key":"10.1016\/j.clinme.2026.100652_bib47","article-title":"Final results of a randomized, controlled, phase 3 trial comparing resection and post-operative stereotactic radiation versus resection and cesium-131 tile-based radiation for treatment of newly diagnosed brain metastases","volume":"44","author":"Weinberg","year":"2026","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clinme.2026.100652_bib48","article-title":"Intraoperative, interstitial brachytherapy in newly diagnosed brain metastases through cesium-131 collagen tile implant: a multi-institutional case series","volume":"8","author":"Chuck","year":"2026","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.clinme.2026.100652_bib49","article-title":"Survival and quality of life after first-time diagnosis of brain metastases: a multicenter, prospective, observational study","volume":"49","author":"Yri","year":"2025","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.clinme.2026.100652_bib50","doi-asserted-by":"crossref","first-page":"E159","DOI":"10.1093\/neuros\/nyy541","article-title":"Congress of neurological surgeons systematic review and evidence-based guidelines on the role of whole brain radiation therapy in adults with newly diagnosed metastatic brain tumors","volume":"84","author":"Gaspar","year":"2019","journal-title":"Clin Neurosurg"},{"issue":"21","key":"10.1016\/j.clinme.2026.100652_bib51","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clinme.2026.100652_bib52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1\u20133 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.clinme.2026.100652_bib53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clinme.2026.100652_bib54","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.clinme.2026.100652_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clinme.2026.100652_bib56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1470-2045(24)00735-6","article-title":"Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study","volume":"26","author":"Long","year":"2025","journal-title":"Lancet Oncol"},{"issue":"Suppl 16","key":"10.1016\/j.clinme.2026.100652_bib57","article-title":"Efficacy of immune checkpoint inhibitors (ICI) in patients (pts) with central nervous system (CNS) metastases (mets) from solid tumors: a systematic review and meta-analysis","volume":"43","author":"Martins","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinme.2026.100652_bib58","article-title":"Osimertinib and stereotactic radiosurgery for brain metastases in EGFR-mutated lung cancer: the STARLET joint analysis of OUTRUN and LUOSICNS randomized trials","volume":"21","author":"Lee","year":"2026","journal-title":"J Thorac Oncol"},{"issue":"17","key":"10.1016\/j.clinme.2026.100652_bib59","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa2503001","article-title":"Overall survival with amivantamab-lazertinib in EGFR-mutated advanced NSCLC","volume":"393","author":"Yang","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clinme.2026.100652_bib60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa2302299","article-title":"Repotrectinib in ROS1 fusion-positive non-small-cell lung cancer","volume":"390","author":"Drilon","year":"2024","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.clinme.2026.100652_bib61","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1200\/JCO.24.01062","article-title":"Taletrectinib: TRUST in the continued evolution of treatments for ROS1 fusion-positive lung cancer","volume":"42","author":"Waliany","year":"2024","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.clinme.2026.100652_bib62","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1200\/JCO.20.00775","article-title":"Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clinme.2026.100652_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/neuonc\/now241","article-title":"Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)","volume":"19","author":"Soffietti","year":"2017","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.clinme.2026.100652_bib64","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1093\/neuros\/nyy546","article-title":"Congress of neurological surgeons systematic review and evidence-based guidelines on the role of steroids in the treatment of adults with metastatic brain tumors","volume":"84","author":"Ryken","year":"2019","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.clinme.2026.100652_bib65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clinme.2026.100652_bib66","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1470-2045(18)30060-3","article-title":"Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial","volume":"19","author":"Vanbutsele","year":"2018","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.clinme.2026.100652_bib67","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.clinme.2026.100652_bib68","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1200\/JCO.24.00542","article-title":"Palliative care for patients with cancer: ASCO guideline update","volume":"42","author":"Sanders","year":"2024","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.clinme.2026.100652_bib69","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2016.16840","article-title":"Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis","volume":"316","author":"Kavalieratos","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clinme.2026.100652_bib70","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41571-024-00970-3","article-title":"Leptomeningeal metastatic disease: new frontiers and future directions","volume":"22","author":"Ozair","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"issue":"33","key":"10.1016\/j.clinme.2026.100652_bib71","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.22.01148","article-title":"Randomized phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis","volume":"40","author":"Yang","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211826001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:57:38Z","timestamp":1793368658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211826001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1470211826001016"],"URL":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100652","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modern multidisciplinary management of brain metastasis","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinme.2026.100652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of Royal College of Physicians.","name":"copyright","label":"Copyright"}],"article-number":"100652"}}